1. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac. (14th February 2017) Authors: Khaliulin, Igor; Bond, Mark; James, Andrew F; Dyar, Zara; Amini, Raheleh; Johnson, Jason L; Suleiman, M‐Saadeh Journal: British journal of pharmacology Issue: Volume 174:Number 6(2017) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗